A neonatal encephalopathy with seizures in standard poodle dogs with a missense mutation in the canine ortholog of ATF2

Neurogenetics

Volumn 9, Issue 1, 2008, Pages 41-49

  Chen, Xuhua ^a   Johnson, Gary S ^a   Schnabel, Robert D ^a   Taylor, Jeremy F ^a   Johnson, Gayle C ^a   Parker, Heidi G ^b   Patterson, Edward E ^c   Katz, Martin L ^a   Awano, Tomoyuki ^a   Khan, Shahwanaz ^a   O'Brien, Dennis P ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Activating transcription factor 2; ATF2; Dogs; Neonatal encephalopathy; Seizures

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2;

ALLELE; ANIMAL TISSUE; ARTICLE; BRAIN DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DOG; GENE MAPPING; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; SEIZURE;

ACTIVATING TRANSCRIPTION FACTOR 2; ALLELES; AMINO ACID SUBSTITUTION; ANIMALS; ANIMALS, NEWBORN; BASE SEQUENCE; BRAIN DISEASES; DNA PRIMERS; DOG DISEASES; DOGS; ELECTROENCEPHALOGRAPHY; FEMALE; HAPLOTYPES; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; METHIONINE; MICE; MICE, KNOCKOUT; MUTATION, MISSENSE; PEDIGREE; SEIZURES; SPECIES SPECIFICITY;

ANIMALIA; CANIS FAMILIARIS; EPICOCCUM; MUS;

EID: 38649095959     PISSN: 13646745     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10048-007-0112-2     Document Type: Article

References (40)

1. American Collge of Obstetricians and Gynecologists (2004) Neonatal encephalopathy and cerebral palsy: executive summary. Obstet Gynecol 103:780-781
2. Wirrell E, Farrell K, Whiting S (2005) The epileptic encephalopathies of infancy and childhood. Can J Neurol Sci 32:409-418
3. Moon PF, Massat BJ, Pascoe PJ (2001) Neonatal critical care. Vet Clin N Am Small Anim Pract 31:343-365
4. Maekawa T, Sakura H, Kanei-Ishii C, Sudo T, Yoshimura T, Fujisawa J, Yoshida M, Ishii S (1989) Leucine zipper structure of the protein CRE-BP1 binding to the cyclic AMP response element in brain. EMBO J 8:2023-2028
5. Newman JR, Keating AE (2003) Comprehensive identification of human bZIP interactions with coiled-coil arrays. Science 300:2097-2101
6. Shimizu M, Nomura Y, Suzuki H, Ichikawa E, Takeuchi A, Suzuki M, Nakamura T, Nakajima T, Oda K (1998) Activation of the rat cyclin A promoter by ATF2 and Jun family members and its suppression by ATF4. Exp Cell Res 239:93-103
7. Monzen K, Hiroi Y, Kudoh S, Akazawa H, Oka T, Takimoto E, Hayashi D, Hosoda T, Kawabata M, Miyazono K, Ishii S, Yazaki Y, Nagai R, Komuro I (2001) Smads, TAK1, and their common target ATF-2 play a critical role in cardiomyocyte differentiation. J Cell Biol 153:687-698
8. Hong S, Choi HM, Park MJ, Kim YH, Choi YH, Kim HH, Choi YH, Cheong J (2004) Activation and interaction of ATF2 with the coactivator ASC-2 are responsive for granulocytic differentiation by retinoic acid. J Biol Chem 279:16996-17003
9. Hayakawa J, Depatie C, Ohmichi M, Mercola D (2003) The activation of c-Jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair. J Biol Chem 278:20582-20592
10. van Dam H, Wilhelm D, Herr I, Steffen A, Herrlich P, Angel P (1995) ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J 14:1798-1811
11. van Dam H, Castellazzi M (2001) Distinct roles of Jun: Fos and Jun: ATF dimers in oncogenesis. Oncogene 20:2453-2464
12. Walton M, Woodgate AM, Sirimanne E, Gluckman P, Dragunow M (1998) ATF-2 phosphorylation in apoptotic neuronal death. Brain Res Mol Brain Res 63:198-204
13. Reimold AM, Grusby MJ, Kosaras B, Fries JW, Mori R, Maniwa S, Clauss IM, Collins T, Sidman RL, Glimcher MJ, Glimcher LH (1996) Chondrodysplasia and neurological abnormalities in ATF-2-deficient mice. Nature 379(6562):262-265
14. Maekawa T, Bernier F, Sato M, Nomura S, Singh M, Inoue Y, Tokunaga T, Imai H, Yokoyama M, Reimold A, Glimcher LH, Ishii S (1999) Mouse ATF-2 null mutants display features of a severe type of meconium aspiration syndrome. J Biol Chem 274:17813-17819
15. Reimold AM, Kim J, Finberg R, Glimcher LH (2001) Decreased immediate inflammatory gene induction in activating transcription factor-2 mutant mice. Int Immunol 13:241-248
16. Otun HA, MacDougall MW, Bailey J, Europe-Finner GN, Robson SC (2005) Spatial and temporal expression of the myometrial mitogen-activated protein kinases p38 and ERK1/2 in the human uterus during pregnancy and labor. J Soc Gynecol Invest 12:185-90
17. Hu MC, Wasserman D, Hartwig S, Rosenblum ND (2004) p38MAPK acts in the BMP7-dependent stimulatory pathway during epithelial cell morphogenesis and is regulated by Smad1. J Biol Chem 279:12051-12059
18. Beier F, Taylor AC, Luvalle P (2000) Activating transcription factor 2 is necessary for maximal activity and serum induction of the cyclin A promoter in chondrocytes. J Biol Chem 275:12948-12953
19. Katz ML, Khan S, Awano T, Shahid SA, Siakotos AN, Johnson GS (2005) A mutation in the CLN8 gene in English Setter dogs with neuronal ceroid-lipofuscinosis. Biochem Biophys Res Commun 327:541-547
20. Redding RW (1987) Electroencephalography. In: Oliver JE, Hoerlein BF, Mayhew IG (eds) Veterinary neurology. Saunders, Philadelphia, pp 111-144
21. Clark LA, Tsai KL, Steiner JM, Williams DA, Guerra T, Ostrander EA, Galibert F, Murphy KE (2004) Chromosome-specific microsatellite multiplex sets for linkage studies in the domestic dog. Genomics 84:550-554
22. Thallman RM, Bennett GL, Keele JW, Kappes SM (2001) Efficient computation of genotype probabilities for loci with many alleles: II. Iterative method for large, complex pedigrees. J Anim Sci 79:34-44
23. Thallman RM, Bennett GL, Keele JW, Kappes SM (2001) Efficient computation of genotype probabilities for loci with many alleles: I. Allelic peeling. J Anim Sci 79:26-33
24. Sobel E, Lange K (1996) Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics. Am J Hum Genet 58:1323-1337
25. Ramensky V, Bork P, Sunyaev S (2002) Human non-synonymous SNPs: server and survey. Nucleic Acids Res 30:3894-3900
26. Bacchelli E, Blasi F, Biondolillo M, Lamb JA, Bonora E, Barnby G, Parr J, Beyer KS, Klauck SM, Poustka A, Bailey AJ, Monaco AP, Maestrini E (2003) Screening of nine candidate genes for autism on chromosome 2q reveals rare nonsynonymous variants in the cAMP-GEFII gene. Mol Psychiatr 8:916-924
27. Kawasaki H, Schiltz L, Chiu R, Itakura K, Taira K, Nakatani Y, Yokoyama KK (2000) ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylation. Nature 405:195-200
28. Livingstone C, Patel G, Jones N (1995) ATF-2 contains a phosphorylation-dependent transcriptional activation domain. EMBO J 14:1785-1797
29. Morton S, Davis RJ, Cohen P (2004) Signalling pathways involved in multisite phosphorylation of the transcription factor ATF-2. FEBS Lett 572:177-183
30. Ouwens DM, de Ruiter ND, van der Zon GC, Carter AP, Schouten J, van der Burgt C, Kooistra K, Bos JL, Maassen JA, van Dam H (2002) Growth factors can activate ATF2 via a two-step mechanism: phosphorylation of Thr71 through the Ras-MEK-ERK pathway and of Thr69 through RalGDS-Src-p38. EMBO J 21:3782-3793
31. Ventura JJ, Kennedy NJ, Lamb JA, Flavell RA, Davis RJ (2003) c-Jun NH2-terminal kinase is essential for the regulation of AP-1 by tumor necrosis factor. Mol Cell Biol 23:2871-82
32. Breitwieser W, Lyons S, Flenniken AM, Ashton G, Bruder G, Willington M, Lacaud G, Kouskoff V, Jones N (2007) Feedback regulation of p38 via ATF2 is essential for survival of embryonic liver cells. Genes Dev 21:2069-82
33. Nagadoi A, Nakazawa K, Uda H, Okuno K, Maekawa T, Ishii S, Nishimura Y (1999) Solution structure of the transactivation domain of ATF-2 comprising a zinc finger-like subdomain and a flexible subdomain. J Mol Biol 287:593-607
34. Bardwell L (2006) Mechanisms of MAPK signalling specificity. Biochem Soc Trans 34:5-41
35. Sharrocks AD, Yang SH, Galanis A (2000) Docking domains and substrate-specificity determination for MAP kinases. Trends Biochem Sci 25:448-453
36. Maekawa T, Shinagawa T, Sano Y, Sakuma T, Nomura S, Nagasaki K, Miki Y, Saito-Ohara F, Inazawa J, Kohno T, Yokota J, Ishii S (2007) Reduced levels of ATF-2 predispose mice to mammary tumors. Mol Cell Biol 27:1730-1744
37. Woo IS, Kohno T, Inoue K, Ishii S, Yokota J (2002) Infrequent mutations of the activating transcription factor-2 gene in human lung cancer, neuroblastoma and breast cancer. Int J Oncol 20:527-531
38. Badawi N, Kurinczuk JJ, Keogh JM, Alessandri LM, O'Sullivan F, Burton PR, Pemberton PJ, Fiona J Stanley FJ (1998) Intrapartum risk factors for newborn encephalopathy: the Western Australian case-control study. BMJ 317:1554-1558
39. Badawi N, Kurinczuk JJ, Keogh JM, Alessandri LM, O'Sullivan F, Burton PR, Pemberton PJ, Fiona J Stanley FJ (1998) Antepartum risk factors for newborn encephalopathy: the Western Australian case-control study. BMJ 317:1549-1553
40. Scher MS (2006) Neonatal seizure classification: a fetal perspective concerning childhood epilepsy. Epilepsy Res 70:S41-S57